Özkara, G. Et Al. 2024. Unusual effects of PCSK9 E670G (rs505151) variation in patients with in-stent restenosis: Variable effects on restenosis risk according to concomitant chronic conditions. NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS , vol.43, no. , 1-21.

Özkara, G., Aslan, E. I., Ceviz, A. B., Candan, G., Malikova, F., Eronat, A. P., ... Ser, Ö. S.(2024). Unusual effects of PCSK9 E670G (rs505151) variation in patients with in-stent restenosis: Variable effects on restenosis risk according to concomitant chronic conditions. NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS , vol.43, no. , 1-21.

Özkara, Gülçin Et Al. "Unusual effects of PCSK9 E670G (rs505151) variation in patients with in-stent restenosis: Variable effects on restenosis risk according to concomitant chronic conditions," NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS , vol.43, no. , 1-21, 2024

Özkara, Gülçin Et Al. "Unusual effects of PCSK9 E670G (rs505151) variation in patients with in-stent restenosis: Variable effects on restenosis risk according to concomitant chronic conditions." NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS , vol.43, no. , pp.1-21, 2024

Özkara, G. Et Al. (2024) . "Unusual effects of PCSK9 E670G (rs505151) variation in patients with in-stent restenosis: Variable effects on restenosis risk according to concomitant chronic conditions." NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS , vol.43, no. , pp.1-21.

@article{article, author={Gülçin Özkara Et Al. }, title={Unusual effects of PCSK9 E670G (rs505151) variation in patients with in-stent restenosis: Variable effects on restenosis risk according to concomitant chronic conditions}, journal={NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS}, year=2024, pages={1-21} }